The Enterprise Value as of November 2025 (TTM) for ALK-Abelló A/S (AKABY) is 50.63B

According to ALK-Abelló A/S’s latest financial reports and current stock price. The company's current Enterprise Value is 50.63B. This represents a change of 40.41% compared to the average of 36.06B of the last 4 quarters.

ALK-Abelló A/S (AKABY) Historical Enterprise Value (quarterly & annually)

How has AKABY Enterprise Value performed in the past?

The mean historical Enterprise Value of ALK-Abelló A/S over the last ten years is 20.26B. The current 50.63B Enterprise Value has changed 24.89% with respect to the historical average. Over the past ten years (40 quarters), AKABY's Enterprise Value was at its highest in in the June 2025 quarter at 41.05B. The Enterprise Value was at its lowest in in the December 2017 quarter at 7.95B.

ALK-Abelló A/S (AKABY) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of ALK-Abelló A/S Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ALK-Abelló A/S (AKABY) Average Enterprise Value

How has AKABY Enterprise Value performed in the past?

The current Enterprise Value of ALK-Abelló A/S (AKABY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

ALK-Abelló A/S (AKABY) Enterprise Value vs. Peers

How is AKABY’s Enterprise Value compared to its peers?

ALK-Abelló A/S’s Enterprise Value is greater than Abcam plc (134.60M), greater than IVERIC bio, Inc. (5.13B), greater than Global Blood Therapeutics, Inc. (-25100000.00), greater than Alpine Immune Sciences, Inc. (4.42B), greater than Arena Pharmaceuticals, Inc. (-183361000.00), greater than Mirati Therapeutics, Inc. (3.93B), greater than Reata Pharmaceuticals, Inc. (6.64B), greater than ChemoCentryx, Inc. (-45263000.00), greater than Turning Point Therapeutics, Inc. (-422300000.00), greater than RayzeBio, Inc. Common Stock (3.63B),

Build a custom stock screener for ALK-Abelló A/S (AKABY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ALK-Abelló A/S using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ALK-Abelló A/S (AKABY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ALK-Abelló A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.